Emyria Ltd (ASX: EMD) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Emyria Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $20.86 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 408.99 million
Earnings per share -0.036
Dividend per share N/A
Year To Date Return -1.92%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Emyria Ltd (ASX: EMD)
    Latest News

    Woman looks amazed and shocked as she looks at her laptop.
    Healthcare Shares

    ASX biotech share rockets 47% on 'landmark decision'

    Australia just became the first country to allow ecstasy and magic mushrooms to be used to treat mental disorders.

    Read more »

    A man in business suit wearing old fashioned pilot's leather headgear, goggles and scarf bounces on a pogo stick in a dry, arid environment with nothing else around except distant hills in the background.
    Cannabis Shares

    Can ASX cannabis shares ever fully recover?

    We take a look at ASX cannabis shares.

    Read more »

    An older farmer wearing a checkered shirt and a straw hat stands in a green field of cannabis plants growing up to waist level as he smiles while thinking about the outlook for ASX cannabis shares in FY23
    Cannabis Shares

    Green shoots or just weeds? The outlook for ASX cannabis shares in FY23

    Are cannabis stocks set to rise along with the broader industry in the new financial year?

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    How did ASX cannabis shares perform in FY22?

    Here's a look at the sector's performance in the financial year just gone.

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    Remember when ASX cannabis shares were smoking hot? Where are they now?

    Newly legalised recreational and medicinal marijuana markets aren't getting the media hype they once did.

    Read more »

    Young adult male farmer standing smiling in his indoor greenhouse full of herbal cannabis plants at a cannabis cultivation facility
    Cannabis Shares

    How have ASX cannabis shares been performing so far in 2022?

    The sector has held its own during volatile times.

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Share Gainers

    These were the best-performing ASX cannabis shares in 2021

    Despite a mixed bag for cannabis shares, some ended the year on a high

    Read more »

    a bearded man with a big smile wearing a bright red apron holds a knife in one hand and a big slab of cheese in the other as though he is about to slice it.
    Share Market News

    Would you like cheese with that? A look at some of Twiggy's highest profile ASX investments of 2021

    Here's the shares Australia's second richest person invested in last year.

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    These were the top performing ASX cannabis shares in November

    It was a tough month for ASX cannabis shares but we've identified 3 diamonds in the rough.

    Read more »

    rising medical asx share price represented by excited doctors dancing in ward
    Healthcare Shares

    3 ASX health care shares that burned the market today

    These three ASX healthcare shares had a great day on the market.

    Read more »

    Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery
    Healthcare Shares

    Here's why the Emyria (ASX:EMD) share price is up 17% to a record high

    What did Emyria announce?

    Read more »

    Bag of white pills spilled onto a blue surface
    Healthcare Shares

    Emyria (ASX:EMD) share price falling on news of MDMA therapy trial

    The Emyria Ltd (ASX: EMD) share price is falling after news from company of a psychedelic therapy program targeting PTSD.

    Read more »

    EMD ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Emyria Ltd

    Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.

    EMD Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    11 Jun 2024 $0.05 $0.00 0.00% 366,641 $0.06 $0.06 $0.05
    07 Jun 2024 $0.06 $0.00 0.00% 68,806 $0.06 $0.06 $0.06
    06 Jun 2024 $0.06 $0.00 0.00% 1,016,912 $0.06 $0.06 $0.06
    05 Jun 2024 $0.06 $0.00 0.00% 397,950 $0.06 $0.06 $0.06
    04 Jun 2024 $0.06 $0.00 0.00% 692,816 $0.06 $0.06 $0.06
    03 Jun 2024 $0.06 $0.00 0.00% 1,538,719 $0.06 $0.06 $0.06
    31 May 2024 $0.06 $0.00 0.00% 24,469 $0.06 $0.06 $0.06
    30 May 2024 $0.06 $0.00 0.00% 28,682 $0.06 $0.06 $0.06
    29 May 2024 $0.06 $0.00 0.00% 86,452 $0.06 $0.06 $0.06
    28 May 2024 $0.06 $0.00 0.00% 302,303 $0.06 $0.06 $0.06
    27 May 2024 $0.06 $0.00 0.00% 1,507,157 $0.06 $0.06 $0.06
    24 May 2024 $0.06 $0.00 0.00% 637,803 $0.06 $0.06 $0.06
    23 May 2024 $0.06 $0.00 0.00% 1,045,417 $0.05 $0.06 $0.05
    22 May 2024 $0.05 $0.00 0.00% 199,082 $0.05 $0.05 $0.05
    21 May 2024 $0.05 $0.00 0.00% 92,609 $0.05 $0.05 $0.05
    20 May 2024 $0.05 $0.00 0.00% 173,018 $0.05 $0.05 $0.05
    17 May 2024 $0.05 $0.00 0.00% 80,889 $0.05 $0.05 $0.05
    16 May 2024 $0.05 $0.00 0.00% 919,700 $0.05 $0.06 $0.05
    15 May 2024 $0.05 $0.00 0.00% 636,526 $0.05 $0.05 $0.05
    14 May 2024 $0.05 $0.00 0.00% 342,374 $0.05 $0.05 $0.05

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    22 Dec 2023 Michael Winlo Buy 100,000 $5,070
    On-market trade.
    09 Oct 2023 Alistair Vickery Buy 32,456 $2,255
    On-market trade.
    05 Oct 2023 Alistair Vickery Issued 32,456 $2,434
    Rights issue.
    05 Oct 2023 Alistair Vickery Issued 25,488 $1,758
    Rights issue. As per announcement on 10-10-2023
    05 Oct 2023 Alistair Vickery Issued 18,519 $1,388
    Rights issue.
    05 Oct 2023 Stewart Washer Issued 666,666 $45,999
    Rights issue. As per announcement on 10-10-2023
    05 Oct 2023 Stewart Washer Issued 1,333,333 $99,999
    Rights issue.
    05 Oct 2023 Michael Winlo Issued 32,148 $2,218
    Rights issue. As per announcement on 10-10-2023
    05 Oct 2023 Michael Winlo Issued 64,297 $4,822
    Rights issue.
    09 Aug 2023 Alistair Vickery Buy 115,418 $10,849
    On-market trade. http://www.aspecthuntley.com.au/asxdata/20231010/pdf/02723469.pdf
    09 Aug 2023 Stewart Washer Buy 225,000 $21,240
    On-market trade.
    08 Aug 2023 Michael Winlo Buy 200,000 $19,200
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Sir John Tooke Non-Executive Director Feb 2020
    Sir Tooke is Executive Chairman of Academic Health Solutions, a start-up Group offering advice to clients internationally on medical research and health service transformation. He is Senior Independent Director at BUPA Chile and was until 2019 non-executive director of the BUPA main Board and the Chair of the Medical Advisory Council. Mr Tooke is also a member of Risk Committee.
    Dr Michael Winlo Managing Director Nov 2019
    Dr Winlo was CEO at Linear Clinical Research Ltd (Linear) until October 2019, a company that provides clinical trial services for US and Asia-based biotech companies. Linear adopt electronic data capture technology. Dr Winlo retains a Directorship at Linear.
    Dr Karen Smith Non-Executive Director Nov 2021
    Dr Smith has overseen more than 100 clinical trials and more than 20 regulatory approvals leading to product launches across diverse therapeutic areas including neuroscience, rare disease, oncology, cardiology, dermatology, oncology and anti-infectives. In addition to R&D and pipeline development, her experience includes the acquisition of U.S. and international companies, divestitures and negotiating partnership deals between biotech and pharma. Dr Smith was recently Chief Medical Officer of Emergent BioSolutions.
    Dr Mohit Kaushal Non-Executive Director Aug 2023
    Dr KaushaL has also been appointed to the FDASIA Workgroup of the Health IT Policy Committee and to the National Committee on Vital and Health Statistics, advising HHS on Data Access and Use.
    Mr Greg Hutchinson Non-Executive Director Nov 2023
    --
    Ms Susan Patricia Park Company Secretary Mar 2023
    -
    Susan Patricia Park Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Dr Stewart James Washer & Dr Patrizia Derna Washer <The Washer Family A/C> 29,950,599 9.71%
    HSBC Custody Nominees (Australia) Limited 24,157,615 7.83%
    Mr Craig Lawrence Darby <Craig Lawrence Darby A/C> 21,109,790 6.85%
    Mal Washer Nominees Pty Ltd <Mal Washer Nominees Pty Ltd> 19,600,000 6.36%
    Mercator Shipwrights Pty Ltd <Mecator A/C> 19,600,000 6.36%
    Mr Sufian Ahmad <Sixty Two Capital A/C> 15,831,766 5.13%
    Mr Pak Lim Kong 6,766,667 2.19%
    Kobala Investments Pty Ltd <Fernando Edward Family A/C> 5,731,960 2.08%
    Mr Stephen Peter Somerville 4,900,000 1.59%
    Mr Bilal Ahmad 3,500,000 1.14%
    Citicorp Nominees Pty Limited 2,872,392 0.93%
    Lakewest Pty Ltd <Raymond Desmond Family A/C> 2,190,000 0.71%
    Mr Hakan Sahin &Mr Gursel Daniskan <Strategic Super A/C> 2,190,000 0.71%
    Mr Steve John Benrnard Grimley 2,166,304 0.70%
    Woodlands Opportunity Fund Pty Ltd 2,031,221 0.66%
    Adam James <Araucaria A/C> 1,960,000 0.64%
    D Schecter Medicine Professional Corporation 1,960,000 0.64%
    Miss Sihong Zeng 1,821,376 0.59%
    Canopy Growth Corporation 1,562,500 0.51%
    Mr Ahmed Noman 1,560,847 0.51%
    Mr Fadi Diab 1,552,941 0.50%
    Mr Dean Brett Blankfield 1,540,177 0.50%

    Profile

    since

    Note